Alberto Onetti – författare
Visar alla böcker från författaren Alberto Onetti. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Business Modeling for Life Science and Biotech Companies
Creating Value and Competitive Advantage with the Milestone Bridge
Inbunden, Engelska, 2014
2 268 kr
Skickas inom 10-15 vardagar
Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Business Modeling for Life Science and Biotech Companies
Creating Value and Competitive Advantage with the Milestone Bridge
Häftad, Engelska, 2018
700 kr
Skickas inom 10-15 vardagar
Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
- Nyhet
Open Innovation in Action
Models, Metrics, and Use-Cases for Corporate-Startup Collaboration
Häftad, Engelska, 2026
555 kr
Skickas inom 10-15 vardagar
The book serves as both a practical guide for managers looking to implement Open Innovation strategies and an authoritative reference for scholars conducting research in the field. Drawing on nearly two decades of combined academic and practitioner experience in entrepreneurship and open innovation, the authors offer a comprehensive, 360-degree perspective on the topic. Specifically, the book offers a fresh, up-to-date, and practice-driven perspective on how large corporations are implementing open innovation today, with a particular focus on startup collaboration and the most recent, real-world best practices.Leveraging privileged access to Mind the Bridge’s extensive activities - including proprietary research data, C-level executive interviews, and global events - this book offers strategies based on an analysis of various companies across sectors, and geographies that have started, scaled, evolved, reshaped, or even abandoned their open innovation journeys. The book helps corporate and startup executives/founders design, refine, and adapt their own open innovation strategies; identify the models that best fit their needs; understand the organizational and cultural conditions required; and, ultimately, track and measure results in a meaningful way.